Wells Fargo lowered the firm’s price target on Clorox (CLX) to $117 from $125 and keeps an Equal Weight rating on the shares. The firm notes the company’s Q1 and FY26 guide were soft albeit amid fears that had built. Wells doesn’t expect much change to narrative here, awaiting needed improvement into the second half of the year and debates on underlying growth into FY27.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
